Loading organizations...
§ Private Profile · Bethesda, MD, USA
Develops and commercializes a non-invasive, AI-driven point-of-care diagnostic platform for rapid evaluation of CAD and PH.
CorVista Health is a Bethesda, Maryland-based medical technology company that develops a non-invasive, artificial intelligence-driven diagnostic platform for the rapid evaluation of cardiovascular conditions. The company's point-of-care system delivers results for coronary artery disease and pulmonary hypertension in under 15 minutes without radiation, serving physicians and clinics in underserved areas. To support its research and commercialization efforts, the enterprise has raised nearly $100 million in total funding, which includes a $65 million Series C round in 2021 and a prior $25 million Series B. The organization operates under the leadership of President and CEO Adrian Lam and Board Chairman Tim Attebery of Cardiovascular Associates of America, with backing from investors such as Ambix Life Science Fund. Originally established as Analytics 4 Life before rebranding in 2020, the company was founded in 2012 by David Trevisani.
CorVista Health has raised $65.0M across 1 funding round.
CorVista Health has raised $65.0M in total across 1 funding round.
CorVista Health has raised $65.0M in total across 1 funding round.
CorVista Health's investors include Peter N. Townshend, MedVenture Partners.
CorVista Health has raised $65.0M across 1 funding round. Most recently, it raised $65.0M Series C in March 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 4, 2021 | $65M Series C | Peter N. Townshend | MedVenture Partners | Announced |